MedPath

Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates

Conditions
Pneumonia
Covid19
Registration Number
NCT04855539
Lead Sponsor
King's College Hospital NHS Trust
Brief Summary

We will determine ventilator outcomes to Coronavirus Infectious Disease 2019 (COVID-19) using artificial Intelligence with inputs of chest radiographs and other evidence-based co-variates.

Detailed Description

The chest radiograph (chest x-ray) has emerged as the United Kingdom's National Health Service (NHS) frontline diagnostic imaging test for COVID-19, in conjunction with clinical history and key blood markers: C-reactive protein (CRP) and lymphopenia. Typically, every suspected COVID-19 patient presenting to the emergency department is undergoing blood tests and a chest radiograph. Therefore, it has become critical for radiologists to review and "hot" report the chest x-ray urgently.

Primary Objective: Use chest radiographs and clinical data to determine whether patient can survive with a ventilator

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria

Admitted to intensive care unit (ITU) or equivalent COVID-19 polymerase chain reaction (PCR) positive

Exclusion Criteria

No imaging prior to ITU admission

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of a convolutional neural network to predict survival outcome1 month

Defined by sensitivity, specificity, positive and negative predictive values

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Princess Royal University Hospital

🇬🇧

Orpington, Kent, United Kingdom

Guy's and St Thomas' Hospital

🇬🇧

London, United Kingdom

King's College Hospital

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath